Skip to content

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer Survivors

Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker That Can Reflect Optimal Health in Prostate Cancer Survivors

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03459755
Enrollment
0
Registered
2018-03-09
Start date
2019-11-27
Completion date
2019-11-27
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Brief summary

The purpose of this study is to show that reduction in advanced glycation end-products (AGEs) is associated with the beneficial regulation of receptor for AGE (RAGE) mediated tumor response which may correlate with improved quality of life in PCa survivors. AGEs are produced by the body and are affected by lifestyle, weight and diet.

Interventions

BEHAVIORALPhysical Activity

Patients will have a baseline assessment by undergoing a maximal exercise testing protocol. For 12 weeks, patients will participate in an exercise session 3 days per week The patient will then enter a 12 week Step Down program in which the number of sessions is decreased to every week, then every 3 weeks. After the second 12-week period, the patient will enter a 28-week follow up period of unsupervised exercise.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patient diagnosed with non-metastatic Stage I-III Prostate Cancer 2. Age 45 years and older 3. Within 12 months of first histologic prostate cancer diagnosis. 4. Completed planned chemotherapy and/or radiation therapy 4 weeks or more prior to study. 5. BMI \> 25 6. ECOG Performance Status 0 or 1. 7. Access to a telephone. 8. Able to read and understand written and spoken English. 9. Participants must be accessible for treatment and follow-up and must sign informed consent. 10. Subjects with known diabetes are permitted. However, they must be under active treatment for this condition. 11. Participants must past the cardiac rehabilitation center stress test.

Exclusion criteria

1. Planned enrollment in other formalized physical activity or diet counseling program during the 12 weeks of study 2. Received chemotherapy or radiation therapy within 4 weeks of enrollment 3. Had previous weight loss surgery (e.g. gastric bypass, sleeve gastrectomy and biliary pancreatic diversion). 4. Previously participated in Cardiac-Rehab 5. Have constrained mobility secondary to problems with balance, bone and/or joint disease 6. Have unstable angina or cardiovascular disease that prohibits exercise.

Design outcomes

Primary

MeasureTime frame
Compare RAGE response (measured in the blood) to changes in Quality of Life using the EORTC QLQ-30 questionnaire.From baseline to up to 52 weeks
Compare RAGE response (measured in the blood) to changes in Quality of Life using the CES-D questionnaire.From baseline to up to 52 weeks

Secondary

MeasureTime frame
Effect of Lifestyle intervention (physical activity and diet) on AGE levels measured in the bloodFrom baseline up to 52 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026